Controlled Release of Core-Shell ZSM-5/chitosan Ellipsoids Loaded with Pifithrin-Α for Enhanced Osteoinductivity

Rong Zhu,Yi-Xuan Chen,Qin-Fei Ke,Chang-Qing Zhang,Ya-Ping Guo

DOI: https://doi.org/10.1016/j.matdes.2017.03.008

IF: 9.417

2017-01-01

Materials & Design

Abstract:For enhanced osteoinductivity to treat effectively with bone defects, the design and fabrication of novel drug delivery systems remain a great challenge. Herein, we for the first time fabricated core-shell ZSM-5/chitosan ellipsoids loaded with pifithrin-α (ZSM-5/CS/PFTα ellipsoids). The ZSM-5 ellipsoids with long-axis lengths of ~400nm and short-axis lengths of ~300nm are constructed by many nanocrystals. The micropores and mesopores that exist respectively within and among the ZSM-5 nanocrystals serve as channels for loading PFTα. The CS on the ZSM-5/CS/PFTα ellipsoids increases drug loading efficiency up to 91.0%, and improves drug sustained release property. The ZSM-5/CS/PFTα ellipsoids possess excellent cytocompatibility, and promote the adhesion, spreading and proliferation of human bone mesenchymal stem cells (hBMSCs). Moreover, the released PFTα from the ZSM-5/CS/PFTα ellipsoids improves the ALP activity of hBMSCs, the mRNA relative expression levels of COL1, OCN and RUNX2, the ECM mineralization and the protein level of β-catenin. The reason is attributed to the fact that the released PFTα as a p53 inhibitor disrupts the ubiquitin-proteasome mediated degradation of β-catenin, resulting in the significant accumulation of β-catenin and the downstream transcription of genes involved in cell survival, proliferation and osteogenic differentiation.